Shanghai Fosun Pharmaceutical (Group) Co Ltd 2013 SR
The report outlines Fosun Pharma's sustainability performance for 2013, highlighting its mission of "Innovation for Good Health." Key developments include the strategic acquisitions of Alma Lasers and Chancheng Hospital to expand healthcare services. The company strengthened its EHS management system, with 16 subsidiaries achieving GMP certification. Environmental efforts focused on energy saving and emission reduction, while social initiatives included extensive anti-malaria aid in Africa and community charity programs. The report also details improvements in corporate governance and internal controls to ensure sustainable growth.
Company: Shanghai Fosun Pharmaceutical (Group) Co Ltd
Sector: Manufacturing
Country: China
Year: 2013
Type: SR
Pages: 120
Shanghai Fosun Pharmaceutical (Group) Co Ltd
The report outlines Fosun Pharma's sustainability performance for 2013, highlighting its mission of "Innovation for Good Health." Key developments include the strategic acquisitions of Alma Lasers and Chancheng Hospital to expand healthcare services. The company strengthened its EHS management system, with 16 subsidiaries achieving GMP certification. Environmental efforts focused on energy saving and emission reduction, while social initiatives included extensive anti-malaria aid in Africa and community charity programs. The report also details improvements in corporate governance and internal controls to ensure sustainable growth.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2013
Reporting Period
Jan 1, 2013 - Dec 31, 2013
Fiscal Year
2013
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Energy Consumption
Water Consumption
Total Waste
Women on Board
Workplace Fatalities
Employees